Device Trial Radar · NCT07857343
CardioFlow Transcatheter Mitral Valve Replacement System Pre-market Clinical Investigation
Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
152
Planned (sponsor's estimate)
Start
Dec 1, 2026
Primary completion
Jan 1, 2030
Study completion Jan 1, 2035
Sponsor
- Lead sponsor
- Shanghai MicroPort CardioFlow Medtech Co., Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 5, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multi-center, single-arm study to assess the safety and effectiveness of Microport CardioFlow Transcatheter Mitral Valve Replacement system in the treatment of moderate to severe or severe degenerative mitral regurgitation and to provide the clinical evidence for product registration in China or other countries
Conditions
- Degenerative Mitral Regurgitation
Interventions
Microport CardioFlow Mitral Valve Replacement SystemDevice
Patients will undergo transcatheter mitral valve replacement using Microport CardioFlow Mitral Valve Replacement System. The device is delivered via a transapical approach under the guidance of medical imaging equipment; the valve product loaded within the delivery system is advanced to the mitral annulus and released, thereby replacing the native mitral valve with pathological changes in function or anatomy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of cumulative all-cause mortality at 12 months post-procedureTime frame: 12 months
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Cardiology
Beijing, China
Cardiology
Kunming, China
Cardiology
Zhengzhou, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.